Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FRANCiS-NF: Fast-track ANC in Suspected Neutropenic Fever
NCT05393505Phase 4Unknown
- Sponsor
- The University of Hong Kong
- Start
- Oct 2022
- Primary completion
- Mar 2025
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial (2 arms), sponsored by The University of Hong Kong. Primary endpoint: Proportion of participants receiving Meropenem at 7 days. Status: unknown.
Beyond the preview
Go deeper on NCT05393505.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05393505.